The need for a preventive agent against dementia led us to screen natural plant resources. Among the herbs and spices tested, sesame seed prepared from Sesamum indicum seeds showed potent β-secretase inhibitory activity. The active principles were determined to be sesamin and sesamolin, typical lignans in S. indicum. The IC 50 values of sesamin and sesamolin were 257 and 140 μM, respectively. These compounds were investigated in a preliminary absorption experiment. After oral administration, these compounds were detected in an intact form in the brain and serum. These results suggest that consumption of sesame seeds may prevent dementia by sesamin and sesamolin, the constituents in sesame seeds.
Dementia has become a serious problem in Japan as the increasing number of patients, expected to reach 7,000,000 by 2025, will lead to major challenges in both treatment and nursing care. Dementia has been categorized into 5 to 6 types, the most dominant being Alzheimer's disease (AD) due to its large number of patients. The main causative factor of AD is senile plaque produced by the amyloid β peptide, which itself is produced by degradation of the amyloid precursor protein catalyzed by secretases. Among the 3 subtypes of secretases, β-secretase is recognized as a promising target for the prevention of AD since inhibition of the enzyme is expected to possess fewer side effects compared to other secretases. Senile plaque destroys brain nerve cells and leads to contraction of the brain. As senile plaque is produced from an early age, we focused on finding a remedy to prevent AD over a long time period. Prevention of AD would be a solution strategy to lower medical expenses and reduce nursing care problems. In our research to discover plant resources effective in the prevention of AD, we have already reported the effectiveness of curry spices (turmeric, curry leaf and black pepper), extracts and spices used in East Asian countries [1] , which were evaluated by the level of inhibitory activity to β-secretase.
In a screening study, we found that the sesame seed extract (Sesamum indicum) showed moderate inhibitory activities [2] . Among the tested extracts, ethyl acetate (EtOAc) extract showed the most potent inhibitory activity of 39% at 250 μg/mL. This prompted us to investigate the active principles of EtOAc extract. Sesame seed is a popular food or spice as well as a source of oil. Sesame oil is known to be a rich source of unsaturated fatty acids including linoleic acid and oleinic acid. In addition, long-term experience of sesame seed consumption has shown it to be safe. From this point of view, sesame seed can be a suitable remedy for the prevention of dementia.
In this report, the inhibitory activities of various extracts, prepared from the seeds of S. indicum, to β-secretase are shown. We also assayed acetylcholinesterase and butyrylcholinesterase to demonstrate the effectiveness of sesame extracts for the treatment of AD since these cholinesterases are successful therapeutic targets. Moreover, the active principles of β-secretase inhibition were determined. In addition, preliminary in vivo assay of the active principles was performed to determine whether the compounds transit to the brain in an intact form.
Results of screening assays of extracts from S. indicum are shown in Tables 1. In the inhibitory assay against β-secretase, the EtOAc extract showed the most potent inhibitory activity among the extracts tested; 39.4% at 250 μg/mL. This result suggests that sesame seeds would be a useful treatment to prevent AD. Furthermore, a relatively low polar extract was dominant for the inhibitory activity. On the other hand, no extracts showed inhibitory effects on both acetylcholinesterase and butyrylcholinesterase, even at a concentration of 250 μg/mL. The activity-guided fractionation of the active principle led to the isolation of two lignans, sesamin and sesamolin ( Figure 1 ). These compounds are typical constituents in sesame seeds, and are known as multi-functional ingredients from extensive published reports [3] . As shown in Table 2 and 3, the inhibitory activities of sesamin and sesamolin (IC 50 ) were 257 and 140 μM, respectively. The inhibitory activities of sesamin and sesamolin were determined for the first time to the best of our knowledge. We successfully found new functional entries for these compounds. Each value represents the mean ± S. D. of triplicates.
Significantly different from the control at **: P <0.01. Inhibitor: Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-Sta-Val-Ala-Glu-Phe. Each value represents the mean ± S. D. of triplicates.
Significantly different from the control at **: P <0.01. Inhibitor: Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-Sta-Val-Ala-Glu-Phe. In the pharmacokinetic studies of sesamin and sesamolin, no pathological abnormality was observed at all doses tested. Sesamin and sesamolin were detected at 38.3 and 174.8 ng/mL in the serum, 28.9 and 88.7 ng/g in the cerebrum and 6.4 and 67.7 ng/g in the cerebellum, respectively, at 1 mg/head dose, at 218.2 and 328.8 ng/mL in the serum, 68.7 and 183.8 ng/g in the cerebrum and 57.9 and 137.5 ng/g in the cerebellum, respectively at 5 mg/head dose, and 281.2 and 624.3 ng/g in the serum, 54.9 and 305.8 ng/mL in the cerebrum and 96.0, 232.6 ng/mL in the cerebellum at 50 mg/head dose, respectively (Figure 4 ). These results suggest that these active compounds had moved to the brain through blood-brain-barrier and can inhibit β-secretase. Moreover, these compounds were detected in proportion to the doses. The oral administration of sesamin has been reported to increase its concentration in the blood using a rat model [4] and to transit to brain through blood-brain barrier [5] . However, the transition of sesamolin to the brain by oral administration has not been reported.
Sesame seeds are consumed all over the world due to their nutritious content. There are many reports on the functional aspects of sesame. Among these, the anti-oxidant effect of sesame has attracted much attention and the active principles were determined to be sesamin and sesamolin [6] . The anti-oxidant activities may lead to the suppressive effect on amyloid β disposition induced by oxidative stress in PC12 cells [7, 8, 9] .
Together, the reported results described above and our results show that sesame seeds, as well as sesamin and sesamolin may be an ideal food and ingredients for the prevention of AD. The contents of sesamin and sesamolin have demonstrated inhibitory activities against β-secretase, reported to be 0.8~1.1% and 0.1~0.7%, respectively. In addition, their total content would be up to 0.6~0.9% [10] . These data suggest that the contents of sesamin and sesamolin in sesame seeds are sufficient to be effective against β-secretase and the prevention of AD by continuous consumption. Sesame is consumed all over the world, especially in India, China, Middle Eastern countries and Japan and may have been effective in preventing AD since ancient times. 
Preparation of extracts for screening:
The sample was pulverized and soaked into 5 volumes/weight of hexane for 1 hour at 40˚C. The suspension was filtered and the residue was again soaked into the same volume of hexane for 30 min at 40˚C. The suspension was filtered and the filtrates were combined and evaporated under reduced pressure to obtain the hexane extract. The residue of hexane extract was dried at room temperature and extracted with EtOAc in the same manner as hexane to obtain the EtOAc extract. MeOH extraction was performed in the same manner as the EtOAc extract to obtain the MeOH extract. The yields of the hexane, EtOAc and MeOH extracts were 50.7, 2.2 and 5.4%, respectively.
Inhibitory assay for β-secretase:
The assay was performed according to the method reported by Murata et al [1] . Samples in a dimethylsulfoxide solution (2 μL), at an appropriate concentration, were diluted with 78 μL of assay buffer (20 mM acetate buffer, pH=4.5 containing 1% triton X-100) in a 96-well microplate. 10 μL of β-secretase solution in assay buffer (17.4 μg protein/mL) was added to the diluted solution, and incubated at 37˚C for 20 min. After incubation, 10 μL of substrate solution with assay buffer (0.1 mM) was added and incubated at 37˚C for 2 h. Fifty μL of reaction The β-secretase inhibitor was used as a reference compound.
Inhibitory assay for acetylcholinesterase: Assays were performed according to the method reported by Marston et al. [11] with modifications in order to introduce a microplate for higher throughput. Samples in a dimethylsulfoxide solution (5 μL) at an appropriate concentration were diluted with 180 μL of assay buffer (50 mM Tris-HCl buffer, pH=7.8) in a 96-well microplate. 10 μL of enzyme solution (2.0 U/mL) and 5 μL of 1-naphthyl acetate (18 mM) were added to the mixture, and incubated at 37˚C for 1 h. After incubation, 25 μL of 5% SDS solution and 25 μL of Fast Blue B Salt solution (2 mM) were added. Absorbance at 600 nm was measured and inhibition was calculated using the equation below.
Inhibition (%) = 100-[(Absorbance from sample group) / (Absorbance from control group) x 100]
Galanthamin hydrobromide was used as a reference drug.
Inhibitory assay for butyrylcholinesterase: Assays were performed as in the case of AChE except for the use of a 5 μL butyrylcholinesterase solution (1.0 U/mL) instead of AChE solution [12] . Tetraisopropylpyrophosphoramide was used as a reference drug.
Fractionation and purification of active principles: EtOAc extract was subjected to silica gel column chromatography using hexane/EtOAc ( .0 for sesamin and +207.6 for sesamolin, c=1.00, CHCl 3 ), NMR and MS spectra with prior reports [13] [14] [15] .
Pharmacokinetic study: All animal experiments were approved by the Institutional Animal Care and Use Committee, and performed according to the Kindai University Animal Experimentation Regulations (Approval number; KAAG-25-002). Five-week-old male Slc:ddy mice (26~28 g, Shimizu Laboratory Supplies, Kyoto,Japan) were fed with a standard diet (Oriental Yeast, Tokyo, Japan) and provided with tap water ad libitum, in a humiditycontrolled room, with a 12-hour light and 12-hour dark cycle. The room temperature was maintained at 25±1˚C. After habituation for 1 week, the mice were divided into three groups (vehicle, sesamin and sesamolin group). min, blood and brain were collected. Serum was obtained by centrifugation at 3,000 rpm for 10 min. Brain samples were quickly frozen in liquid nitrogen, and stored at -80°C until analysis by LC-MS.
LC-MS analysis of sesamin and sesamolin in serum and tissue sample: Plasma extraction: Plasma sample (100 μL) and 500 μL of MeCN were combined and extracted by 3 min of vortex. The solution was then centrifuged (3,000 rpm for 3 min). The supernatant was evaporated under reduced pressure and the residue was dissolved into 50 μL of MeCN for LC-MS analysis.
Brain extraction: Brain sample (30 mg) was pulverized and extracted with 150 μL of MeCN. After 10 min of vortex and sonication, the suspension was centrifuged at 3,000 rpm for 3 min. The supernatant was evaporated under reduced pressure and the residue was dissolved into 75 μL of MeCN for LC-MS analysis. Statistical Analysis: All data were analyzed statistically using oneway analysis of variance (ANOVA) followed by a multiple comparison test by Bonferroni/Dunn algorithm. The analyses were performed using Statcel 3 (The Publisher OMS Ltd., Saitama, Japan) software. The data are shown in means of triplicates with error bars indicating standard deviations.
